Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis

George C. Liang*, Magaly Cordero, Alan Dyer, Rowland W. Chang

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Current tumor necrosis factor-α inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Nursing and Health Professions